Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.

por Georgina Arrambide, Carmen Espejo, Jennifer Yarden, Ella Fire, Larissa Spector, Nir Dotan, Avinoam Dukler, Alex Rovira, Xavier Montalban, Mar Tintore
Publicado 2013

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

por Carmen Tur, Mar Tintoré, Ángela Vidal-Jordana, Denis Bichuetti, Pablo Nieto González, María Jesús Arévalo, Georgina Arrambide, Elisenda Anglada, Ingrid Galán, Joaquín Castilló, Carlos Nos, Jordi Río, María Isabel Martín, Manuel Comabella, Jaume Sastre-Garriga, Xavier Montalban
Publicado 2013

Radiologically isolated syndrome: 5-year risk for an initial clinical event.

por Darin T Okuda, Aksel Siva, Orhun Kantarci, Matilde Inglese, Ilana Katz, Melih Tutuncu, B Mark Keegan, Stacy Donlon, Le H Hua, Angela Vidal-Jordana, Xavier Montalban, Alex Rovira, Mar Tintoré, Maria Pia Amato, Bruno Brochet, Jérôme de Seze, David Brassat, Patrick Vermersch, Nicola De Stefano, Maria Pia Sormani, Daniel Pelletier, Christine Lebrun, Radiologically Isolated Syndrome Consortium (RISC), Club Francophone de la Sclérose en Plaques (CFSEP)
Publicado 2014